Tadalafil
Product Images NDC 50436-0372

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 50436-0372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl504360372)

Label for Tadalafil 20 mg tablets in a package of 6 tablets, manufactured by Litho Pharm Limited, India, and labeled by Unit Dose Services, LLC. The label includes dosage strength, packaging instructions, safety warnings, and lot/expiration date fields, with barcode and NDC details (50436-0372). It is marked RX Only.*

FDA Label Image

Figure (Tadalafil Figure1)

Four line graphs displaying the difference in blood pressure (Tadalafil minus placebo) over time in hours. The graphs, labeled Standing Systolic BP, Standing Diastolic BP, Supine Systolic BP, and Supine Diastolic BP, show measurements from 0 to 96 hours. The y-axis indicates blood pressure difference in mmHg.*

FDA Label Image

Figure (Tadalafil Figure2)

This image contains two line graphs depicting the effects of Tadalafil 20 mg & doxazosin 8 mg versus placebo & doxazosin 8 mg on systolic blood pressure over 24 hours post-dose. The top graph shows standing systolic blood pressure changes, and the bottom graph displays supine systolic blood pressure changes with time on the x-axis and blood pressure in mmHg on the y-axis.*

FDA Label Image

Figure (Tadalafil Figure3)

A line graph showing systolic blood pressure (mmHg) over time (hours) after administration of tadalafil or placebo combined with doxazosin. Four data series compare 20 mg tadalafil taken at 08:00 or 20:00 with 8 mg doxazosin at 08:00, against placebo taken at the same times with 8 mg doxazosin. The graph depicts blood pressure changes up to 12 hours post-dose.*

FDA Label Image

Figure (Tadalafil Figure4)

A line chart showing plasma tadalafil concentration (µg/L) over time (hours). It compares single 20-mg and 5-mg tadalafil doses with once-daily 5-mg tadalafil administration over 5 consecutive days, including error bars for each data point.*

FDA Label Image

Figure 5 (Tadalafil Figure5)

A line graph comparing the change from baseline in IPSS total score over 12 weeks of treatment, showing tadalafil 5 mg versus placebo. The vertical axis represents the change in score, and the horizontal axis shows treatment duration in weeks. Data points indicate that tadalafil 5 mg shows a greater reduction in score compared to placebo, with statistical significance noted at certain time points.*

FDA Label Image

Figure 6 (Tadalafil Figure6)

A line graph comparing the change from baseline in IPSS total score over a 12-week treatment duration between tadalafil 5 mg and placebo. The graph shows a greater decrease in score with tadalafil compared to placebo, with statistical significance indicated at certain points.*

FDA Label Image

Figure 7 (Tadalafil Figure7)

A line graph depicting weeks of therapy (0 to 26) on the x-axis and least squares mean change from baseline on the y-axis. It compares Tadalafil/Finasteride and Placebo/Finasteride treatments, showing numerical LS mean differences at weeks 4, 12, and 26, with annotations for statistical significance (p<0.001 and p<0.05).*

FDA Label Image

Figure 8 (Tadalafil Figure8)

Line graph comparing the change from baseline in IPSS Total Score over weeks of treatment between tadalafil 5 mg and placebo groups. The graph shows greater score reduction with tadalafil over 12 weeks. The x-axis represents duration of treatment in weeks; the y-axis represents change from baseline in IPSS Total Score.*

FDA Label Image

Chemical Structure (Tadalafil Structure)

Chemical structure of Tadalafil showing its molecular configuration with distinct rings and functional groups as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.